Small Pharma Inc.
DMTTF · OTC
2/28/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | – | – | 100% | – |
| EBITDA | -$0 | -$0 | -$0 | – |
| % Margin | – | – | -12,447.8% | – |
| Net Income | -$0 | -$0 | -$0 | – |
| % Margin | – | – | -9,061.1% | – |
| EPS Diluted | -0.071 | -0.072 | -0.022 | – |
| % Growth | 0.7% | -222.1% | – | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | – |
| Capital Expenditures | -$0 | -$0 | -$0 | – |
| Free Cash Flow | -$0 | -$0 | -$0 | – |